» Articles » PMID: 26283331

A Single Amino Acid Replacement in the Sensor Kinase LiaS Contributes to a Carrier Phenotype in Group A Streptococcus

Overview
Journal Infect Immun
Date 2015 Aug 19
PMID 26283331
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the high frequency of asymptomatic carriage of bacterial pathogens, we understand little about the bacterial molecular genetic underpinnings of this phenomenon. To obtain new information about the molecular genetic mechanisms underlying carriage of group A Streptococcus (GAS), we performed whole-genome sequencing of GAS strains recovered from a single individual during acute pharyngitis and subsequent asymptomatic carriage. We discovered that compared to the initial infection isolate, the strain recovered during asymptomatic carriage contained three single nucleotide polymorphisms, one of which was in a highly conserved region of a gene encoding a sensor kinase, liaS, resulting in an arginine-to-glycine amino acid replacement at position 135 of LiaS (LiaS(R135G)). Using gene replacement, we demonstrate that introduction of the carrier allele (liaS(R135G)) into a serotype-matched invasive strain increased mouse nasopharyngeal colonization and adherence to cultured human epithelial cells. The carrier mutation also resulted in a reduced ability to grow in human blood and reduced virulence in a mouse model of necrotizing fasciitis. Repair of the mutation in the GAS carrier strain restored virulence and decreased adherence to cultured human epithelial cells. We also provide evidence that the carrier mutation alters the GAS transcriptome, including altered transcription of GAS virulence genes, providing a potential mechanism for the pleiotropic phenotypic effects. Our data obtained using isogenic strains suggest that the liaS(R135G) mutation in the carrier strain contributes to the transition from disease to asymptomatic carriage and provides new information about this poorly described regulatory system in GAS.

Citing Articles

LiaR-dependent gene expression contributes to antimicrobial responses in group A .

Vega L, Sanson-Iglesias M, Mukherjee P, Buchan K, Morrison G, Hohlt A Antimicrob Agents Chemother. 2024; 68(12):e0049624.

PMID: 39535201 PMC: 11619527. DOI: 10.1128/aac.00496-24.


Identification of distinct impacts of CovS inactivation on the transcriptome of acapsular group A streptococci.

DebRoy S, Shropshire W, Vega L, Tran C, Horstmann N, Mukherjee P mSystems. 2023; 8(4):e0022723.

PMID: 37358280 PMC: 10470059. DOI: 10.1128/msystems.00227-23.


Population Genomics of Group A Streptococcus Reveals Progressive Replacement with a Hypervirulent Clone in North America.

DebRoy S, Sanson M, Shah B, Regmi S, Vega L, Odo C mSystems. 2021; 6(4):e0049521.

PMID: 34374563 PMC: 8409732. DOI: 10.1128/mSystems.00495-21.


The LiaFSR Transcriptome Reveals an Interconnected Regulatory Network in Group A Streptococcus.

Sanson M, Vega L, Shah B, Regmi S, Cubria M, Horstmann N Infect Immun. 2021; 89(11):e0021521.

PMID: 34370508 PMC: 8519277. DOI: 10.1128/IAI.00215-21.


("Group A Streptococcus"), a Highly Adapted Human Pathogen-Potential Implications of Its Virulence Regulation for Epidemiology and Disease Management.

Siemens N, Lutticken R Pathogens. 2021; 10(6).

PMID: 34205500 PMC: 8234341. DOI: 10.3390/pathogens10060776.


References
1.
Sitkiewicz I, Musser J . Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group a streptococcus. Infect Immun. 2006; 74(2):1339-51. PMC: 1360370. DOI: 10.1128/IAI.74.2.1339-1351.2006. View

2.
Lancefield R . Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med. 1959; 110(2):271-92. PMC: 2136986. DOI: 10.1084/jem.110.2.271. View

3.
Walker M, Barnett T, McArthur J, Cole J, Gillen C, Henningham A . Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 2014; 27(2):264-301. PMC: 3993104. DOI: 10.1128/CMR.00101-13. View

4.
Mascher T, Helmann J, Unden G . Stimulus perception in bacterial signal-transducing histidine kinases. Microbiol Mol Biol Rev. 2006; 70(4):910-38. PMC: 1698512. DOI: 10.1128/MMBR.00020-06. View

5.
Wertheim H, Melles D, Vos M, van Leeuwen W, van Belkum A, Verbrugh H . The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005; 5(12):751-62. DOI: 10.1016/S1473-3099(05)70295-4. View